Trans-Carotid Artery Revascularization

Version 1.0 ; 12/2020

Andrew Schober & Michael Bokoch

Trans-Carotid Artery Revascularization (TCAR)
Carotid stenting is an alternative to carotid endarterectomy which is traditionally reserved for patients with high surgical risk or those with anatomy not amenable to open repair (e.g. distal lesions). Trans-carotid artery revascularization (TCAR) is an alternative to typical trans-femoral stenting. TCAR is meant to decrease the risk of micro-embolic stroke by reversing flow in the carotid artery during stenting (see below).

1. Procedure description
Exposure of the common carotid artery is obtained via a small incision above the clavicle. A flexible sheath is placed into the carotid artery and connected to the flow reversal system. The femoral vein is simultaneously exposed or accessed percutaneously and a second sheath placed in the vein. The distal end of the flow reversal system is then attached to this venous sheath such that blood will flow from the high-pressure carotid artery to the low-pressure femoral vein. 

Once wires are correctly positioned in the ICA +/- ECA, flow reversal is initiated. Balloon angioplasty followed by stenting and additional ballooning to stabilize the stent is performed. After a 3 minute washout period, flow reversal is discontinued, sheaths removed and arteriotomy closed.

More information and a video showing the procedure is included on the device manufacturer’s website.

2. Patient demographics
Risk factors for carotid stenosis are similar to those for atherosclerotic heart disease including older age, hypertension, diabetes, obesity, metabolic syndrome, hyperlipidemia, smoking, sedentary lifestyle, and family history of atherosclerosis. As such, there is considerable comorbid cardiovascular disease including hypertension, coronary artery disease, heart failure, valvular disease, and peripheral vascular disease, all which can affect the ability to effectively manage hemodynamics and put the patient at elevated risk of cardiovascular complications (including hemodynamic instability / vasoplegia, MI, stroke, arrhythmia, etc).

Symptomatic : stroke or TIA referable to the appropriate carotid artery distribution within the previous six months AND carotid stenosis > 50%.
Asymptomatic : atherosclerotic narrowing of the extracranial ICA (>80%) without recent stroke or TIA (Of note, vertigo and syncope are not typical manifestations)

Of the patients eligible for carotid surgery, the decision to stent as opposed to an open repair is primarily based an elevated level of either surgical or cardiovascular risk. Any one of the following qualify a patient for high-risk status :

  • Age > 75
  • CHF
  • LVEF < 35%
  • >2 diseased coronaries w/ 70% stenosis
  • Unstable angina
  • MI within 6 weeks
  • Abnormal stress test
  • Need for open heart surgery
  • Need for major surgery (including vascular)
  • Uncontrolled diabetes
  • Severe pulmonary disease
  • Prior head/neck surgery or irradiation
  • Spinal immobility 
  • Restenosis post CEA
  • Surgically inaccessible lesion
  • Laryngeal palsy; Laryngectomy
  • Permanent contralateral cranial nerve injury
  • Contralateral occlusion
  • Severe tandem lesions
  • Bilateral stenosis requiring treatment

3. Preoperative Assessment
This should focus on an evaluation of comorbid disease, and as described above, which could negatively impact effective blood pressure management and result in an elevated risk of cardiovascular complications. All carotid surgery falls into the high-risk category. Pre-surgical testing should follow AHA/ACA guidelines for high-risk noncardiac surgery.

  • 12 lead EKG, standard
  • Labs (including CBC, electrolytes, creatinine, coags)
  • CT angiogram vs. carotid ultrasound to define anatomy (surgeon’s pervue)
  • Consider exercise or pharmacologic stress test if functional status poor or unknown and patient is at elevated risk (>1%) of MACE based on VQI or NSQIP calculator
  • Consider TTE if concerned for heart failure, pulmonary hypertension, or valvular disease as these may impair the ability to effectively induce hypertension required during flow reversal

The urgency of the procedure, based on whether the patient is symptomatic or not, should also factor into the decision to obtain additional testing. As is often the case, one needs to weigh the benefits of additional diagnostic information against the cost of delaying the procedure.

4. Preoperative Preparations

  • Patient should be on dual anti-platelet therapy (Aspirin / Plavix) + statin for a minimum of 7 days prior to the procedure. This should be continued throughout the perioperative period. If patient has missed a dose, including on the day of surgery, discuss with surgeon and likely re-dose (or even re-load) in preop prior to surgery. 
  • Continue any previous prescribed beta blockers
  • Carefully consider continuing vs. discontinuing other anti-hypertensives; consider stopping ACEi / ARBs as refractory post-induction hypotension can compromise cerebral perfusion and make induced hypertension during flow reversal difficult

5. Access/Fluids

  • Generally 2 good PIVs are adequate, but one should be confident in the integrity of those lines as vasopressors / vasodilators will be required during critical portions of the procedure
  • If central access is needed, recommend contralateral IJ / subclavian vs. femoral access
  • No restrictions / requirement for fluids per say. It is worth carefully assessing volume status as many of these patients are on diuretics or undergoing hemodialysis for concomitant renal and cardiovascular disease. Relative hypovolemia may adversely affect the ability to achieve induced hypertension required during flow reversal.
  • Patients should be type & crossed for at least 2 units of PRBCs ; can consider more depending on the preoperative Hgb.

6. Monitors

  • Standard ASA monitors plus…
  • Pre-induction arterial line for strict blood pressure monitoring
  • Cerebral oximetry to monitor adequacy of collateral circulation via the Circle of Willis during flow reversal
  • ACT monitoring during heparinization (target 280-340 seconds)
  • Attempt to run all radio-opaque monitoring cables (with the exception of the cerebral oximeter) off the right flank and bundle w/ tourniquet/blue clamp combo. Run the cerebral oximeter cables, a.line, and PIVs around the periphery of the head of bed and bundle. This keeps our lines out of the fluoroscopy path.

7. Anesthetic Technique
This procedure can be performed under either MAC or general anesthesia. Determination of anesthetic technique is based largely on neck anatomy (obese patients may require more stimulating/deeper neck dissection) and the patient’s ability to tolerate lying still for the duration of the procedure. Additional consideration should be given to the extent of comorbidities. This means that, the sicker the patient, the more consideration given to performing the procedure under MAC. For MAC cases, consider dexmedetomidine + low-dose remifentanil infusions. For less sick patients (cardiovascularly and neurologically robust), more consideration should be given to GETA.

Superficial Cervical Plexus Block

Occasionally considered for TCAR done under MAC or as an adjunct to GA to improve pain control and limit the dose of general anesthesia. Due to the location of the incision above the clavicle (in contrast to the larger, more cranially-oriented CEA incision), one really only needs to perform the lower portion of the injections. Recommend performing this as a field block by landmarks since it is faster and equally as effective as ultrasound-guided.

  1. Control syringe, ~25g needle
  2. 10mL of 0.5% Ropiv or 0.25% Bupiv (consider adding mepivacaine if case done under MAC)
  3. Locate posterior border of sternocleidomastoid (SCM)
  4. Mark mid-point between mastoid process and clavicle
  5. Enter posterior to SCM, 0.5-1 cm deep, aspirate
  6. Inject 4 mL, fan cephalad (3 mL), fan caudad (3 mL)

8. Key procedure related points

  • Confirm with patient in preop that they took Dual Antiplatelet Therapy (DAPT) the morning of surgery. If inpatient, check MAR to confirm. If not taken, discuss with surgeon.
  • Arrange lines out of surgical field / fluoro trajectory (see above). Insure nothing under the head except donut head padding. Consider checking with fluoro prior to surgical exposure.
  • Blood pressure maintained at baseline or slightly above during surgical exposure.
  • Premedicate w/ glycopyrrolate, unless medically contraindicated (HR > 90 at baseline, severe CAD at risk for cardiac ischemia) to prevent bradycardia / asystole during ballooning at or near carotid baroreceptors
  • During flow reversal, maintain SBP > 160 (adjust based on baseline BP, usually 15-20% above baseline) to aid in perfusion via Circle of Willis (CoW). Monitor rSO2 (cerebral oximeter) and flow through TCAR circuit closely during this period – both are measures of adequate CoW perfusion.
  • Consider decreasing or stopping vasopressors after stent deployment (during 3-min washout period) as once this step is complete, BP goals immediately shift to SBP 110 - 140 to prevent cerebral hyperperfusion; may need boluses of esmolol or nicardipine / clevidipine to achieve this rapidly
  • Post-stenting hypotension is common due to persistent carotid baroreceptor stimulation and often requires vasopressor support to insure adequate cerebral perfusion until hemodynamics stabilize.
  • Routine admission to the ICU for 24 hours for close neurologic and hemodynamic monitoring.

9. Potential complications

  • embolic stroke : during exposure or due to insufficient flow reversal
  • stroke due to hypoperfusion / insufficient collateral flow via Circle of Willis ; watershed infarct
  • bleeding due to catheter dislodgement : higher risk during MAC as opposed to GA
  • reperfusion injury : ipsilateral ACA/MCA distribution now seeing higher pressure and flow since no longer obstructed by stenotic segment of carotid artery. Stroke like syndrome which can manifest as encephalopathy or unilateral sensory / motor deficits, seizure, or rarely, intracranial hemorrhage

10. Positioning / ergonomic considerations

  • supine, ipsilateral neck and either groin are prepped
  • neck extended with shoulder roll and head rotated away from surgical side to improve exposure
  • lines bundled at edges of bed, nothing under the patient’s head ; consider checking w/ fluoroscopy prior to exposure to confirm not in XR path
  • drape will be adjacent to patient’s face as it is not feasible to create a large space due to surgical access considerations
  • the above conditions result in difficult airway access during MAC if conversion to GETA is required

11. Duration of case
Surgical time : 60-90 min
Total OR time : 120-180 min

Clinical Area: 
Type: 

 

This information is meant to serve as an educational resource. Clinicians should use their own professional judgment in the care of any individual patient as the guidance contained in this document may not be appropriate for all patients or all situations.